Wolverine Trading
SGMO

Wolverine Trading’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Wolverine Trading’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$16.7K Buy
+23,799
New +$12.8K ﹤0.01% 5547
2025
Q2 		– Sell
-25,486
Closed -$15.1K – 5475
2025
Q1 		$20.9K Buy
25,486
+5,246
+26% +$5.55K ﹤0.01% 4556
2024
Q4 		$47.4K Buy
20,240
+3,743
+23% +$6.84K ﹤0.01% 4999
2024
Q3 		$14.3K Buy
+16,497
New +$12.1K ﹤0.01% 4663
2021
Q2 		– Sell
-12,129
Closed -$137K – 6606
2021
Q1 		$142K Sell
12,129
-17,157
-59% -$231K ﹤0.01% 5269
2020
Q4 		$494K Buy
29,286
+17,001
+138% +$199K ﹤0.01% 3188
2020
Q3 		$121K Sell
12,285
-3,153
-20% -$34.1K ﹤0.01% 4069
2020
Q2 		$135K Sell
15,438
-20,602
-57% -$191K ﹤0.01% 4029
2020
Q1 		$234K Sell
36,040
-48,078
-57% -$357K ﹤0.01% 3498
2019
Q4 		$686K Sell
84,118
-5,590
-6% -$51.4K ﹤0.01% 2772
2019
Q3 		$824K Sell
89,708
-10,961
-11% -$123K ﹤0.01% 2135
2019
Q2 		$1.08M Sell
100,669
-17,429
-15% -$185K ﹤0.01% 1975
2019
Q1 		$1.13M Sell
118,098
-37,520
-24% -$383K ﹤0.01% 1959
2018
Q4 		$1.69M Buy
155,618
+137,927
+780% +$1.71M ﹤0.01% 1551
2018
Q3 		$300K Buy
+17,691
New +$269K ﹤0.01% 3732
2018
Q1 		– Sell
-62,515
Closed -$1.34M – 5765
2017
Q4 		$1.02M Buy
62,515
+19,614
+46% +$292K ﹤0.01% 2174
2017
Q3 		$644K Buy
42,901
+5,015
+13% +$55.4K ﹤0.01% 2340
2017
Q2 		$337K Buy
37,886
+20,330
+116% +$130K ﹤0.01% 2874
2017
Q1 		$83K Buy
17,556
+1,578
+10% +$6.33K ﹤0.01% 3879
2016
Q4 		$49K Buy
+15,978
New +$58.2K ﹤0.01% 4214
2016
Q3 		– Sell
-28,316
Closed -$144K – 5063
2016
Q2 		$163K Buy
+28,316
New +$180K ﹤0.01% 3406

Other funds holding SGMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Wolverine Trading's SGMO Position: Q3 2025 in Review

Wolverine Trading opened a new position in SANGAMO THERAPEUTICS INC (SGMO) in Q3 2025: 23,799 shares worth $16.7K. The stake represents ﹤0.01% of the portfolio and ranks #5547 among its holdings. This is a return to the name: Wolverine Trading previously reported a position in SGMO as recently as Q1 2025.

Wolverine Trading first reported a position in SGMO in Q2 2016 and has held it in 21 quarters since. The position peaked at $1.69M in Q4 2018. 112 funds tracked by Wall St. Rank hold SGMO as of Q3 2025.

  • Wolverine Trading held 23,799 shares of SANGAMO THERAPEUTICS INC worth $16.7K as of Q3 2025.
  • SANGAMO THERAPEUTICS INC was a new Wolverine Trading position in Q3 2025.
  • SANGAMO THERAPEUTICS INC made up ﹤0.01% of Wolverine Trading's portfolio in Q3 2025, its #5547 holding.
  • Wolverine Trading first reported a position in SANGAMO THERAPEUTICS INC in Q2 2016 and has held it in 21 quarters since.
  • Wolverine Trading's SANGAMO THERAPEUTICS INC position peaked at $1.69M in Q4 2018.
  • 112 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q3 2025.

Based on Wolverine Trading's 13F filing for Q3 2025, filed 14 Nov 2025.